| Bioactivity | GSK2236805 is a potent hepatitis C virus inhibitor with pEC50 values of 10.4, 11.1 for HCV genotype 1a (gt1a) and gt1b, respectively[1]. |
| Target | pEC50: 10.4 (gt1a); 11.1 µM (gt1b) |
| Name | GSK2236805 |
| CAS | 1256390-53-0 |
| Formula | C42H52N8O8 |
| Molar Mass | 796.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kazmierski WM, et al. Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound. J Med Chem. 2014 Mar 13;57(5):2058-73. |
GSK2236805
CAS: 1256390-53-0 F: C42H52N8O8 W: 796.91
GSK2236805 is a potent hepatitis C virus inhibitor with pEC50 values of 10.4, 11.1 for HCV genotype 1a (gt1a) and gt1b,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.